Simos Simeonidis, Ph.D.

Dr. Simos Simeonidis is Managing Partner of Kos Biotechnology Partners, a global life sciences investment firm he founded in 2024. He is also the Co-Founder, Chairman of the Board and interim CEO of Delsona Therapeutics, a healthcare company he spun out of Columbia University, that uses Focused Ultrasound to deliver therapeutics through the Blood Brain Barrier into the CNS, with applications in neurology (Alzheimer’s, Parkinson’s, ALS etc) and oncology (Glioblastoma Multiforme, DIPG etc).